Last reviewed · How we verify

5% Albumin infusion 3 hours — Competitive Intelligence Brief

5% Albumin infusion 3 hours (5% Albumin infusion 3 hours) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Plasma expanders. Area: Hematology.

marketed Plasma expanders Intravascular volume and oncotic pressure Hematology Small molecule Live · refreshed every 30 min

Target snapshot

5% Albumin infusion 3 hours (5% Albumin infusion 3 hours) — Region Skane. 5% Albumin infusion works by increasing intravascular volume and maintaining oncotic pressure, thereby improving blood flow and tissue perfusion.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
5% Albumin infusion 3 hours TARGET 5% Albumin infusion 3 hours Region Skane marketed Plasma expanders Intravascular volume and oncotic pressure

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Plasma expanders class)

  1. Region Skane · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). 5% Albumin infusion 3 hours — Competitive Intelligence Brief. https://druglandscape.com/ci/5-albumin-infusion-3-hours. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: